The future of healthcare is here.
Join us as Cleveland Clinic and IBM partner to host the inaugural Cleveland Discovery and Innovation Forum to explore cutting-edge healthcare and life sciences research powered by high-performance computing.
International leaders in academia, industry and government will come together to discuss new discoveries and advancements made possible by quantum computing, artificial intelligence and digital health.
Learn about select Discovery Accelerator scientific projects and network with the project teams. The Cleveland Clinic Quantum Innovation Catalyzer Program will announce its first participants.
Health inequity is a pervasive challenge across the globe. At the macro-system level, major treatment and diagnostic gaps exist between the developed and the developing world, while at the micro-system level, health disparities discriminate between privileged and underprivileged communities in wealthy nations. This session explores how technology can bridge those gaps and highlights relevant policy considerations.
Innovation demands comfort with high-risk, high-reward big ideas; but traditional funding mechanisms are traditionally aligned to support incremental progress. Effective translation to practice requires transitioning research ideas to practical outputs; but commercialization is often considered very late in the research process. This session (panel discussion) will explore how to accelerate the exploration of transformative ideas and their translation to practice through collaboration among government agencies, venture funds, and foundations.
Cleveland Clinic and IBM have entered into a 10-year partnership to establish the Discovery Accelerator — a joint center that utilizes Cleveland Clinic’s research and clinical expertise and IBM’s global leadership in computing technologies. The goal of the partnership is to advance the pace of discovery in healthcare and life sciences by using high-performance computing — including the hybrid cloud, artificial intelligence and quantum computing technologies.
Contact Cleveland Clinic's Center for Computational Life Sciences at ComputationalLifeSci@ccf.org.
Tom Mihaljevic, MD, is Chief Executive Officer and President of Cleveland Clinic, leading an $8 billion healthcare system that includes a main campus in Cleveland, Ohio, 11 regional hospitals, 18 family health centers, and facilities in Florida, Nevada, Toronto, Abu Dhabi, and London. Dr. Mihaljevic previously served as CEO of Cleveland Clinic Abu Dhabi (CCAD), where he oversaw the opening of the 365-bed hospital and clinic, with 3,000 caregivers, in 2015. Under his leadership, CCAD expanded its treatment capabilities, built relationships in the private and public sectors, and established its growing reputation for clinical excellence, research, and education. From 2010 to 2015, Dr. Mihaljevic was chief of staff and chairman of the Heart, Vascular & Thoracic Institute at CCAD. He led a recruitment effort that drew 5,500 applications for 175 physician posts, and went on to launch the most advanced cardiovascular program in the Middle East. Dr. Mihaljevic joined Cleveland Clinic in 2004 as a surgeon in the Department of Thoracic and Cardiovascular Surgery. He has performed almost 3,000 operations over the course of his career, specializing in minimally invasive and robotically assisted procedures, valve replacement and repair, image-guided surgery, heart failure and cardiac transplantation.
Welcome and Panel Introduction
Featuring:
Tom Mihaljevic, MD | CEO & President, Cleveland Clinic
Brian Donley, MD | CEO, Cleveland Clinic London
Jamanda Haddock, MA, MRCP, FRCR | Associate Chief of Staff and Chair of Hospital Services, Cleveland Clinic London
Moderated by: Angela Rossi, Chief Human Resources Officer
Panel Discussion and Audience Q&A
Chair of the Board Remarks | Beth Mooney
Ribbon Cutting Ceremony
